Zimmer Biomet (ZBH) PT Lowered to $140 at Deutsche Bank

Go back to Zimmer Biomet (ZBH) PT Lowered to $140 at Deutsche Bank

Zimmer Biomet (ZBH) PT Lowered to $175 at Jefferies

November 5, 2021 8:17 AM EDT

Jefferies analyst Raj Denhoy lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $200.00) while maintaining a Buy rating.

The analyst commented, "Key 2Q post call details: 1) Delta/Staffing impacts are expected to persist into 4Q at heightened level, 2) China VBP... More